Welcome to our dedicated page for Lifemd news (Ticker: LFMDP), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.
LifeMD, Inc. (LFMDP) provides a centralized news hub for investors and healthcare professionals tracking advancements in integrated telehealth solutions. This resource aggregates official announcements regarding service expansions, technology innovations, and operational milestones within LifeMD's HIPAA-compliant ecosystem.
Access timely updates on virtual care initiatives, including developments in remote diagnostics, digital prescription systems, and secure provider-patient communication platforms. The curated news collection enables stakeholders to monitor strategic partnerships, regulatory compliance achievements, and enhancements to the company's clinician-centric EMR infrastructure.
All content reflects LifeMD's commitment to advancing accessible healthcare through AES-encrypted telemedicine services and custom diagnostic equipment. Bookmark this page for verified updates about operational developments that shape the company's position in the digital health sector.
LifeMD, Inc. (NASDAQ: LFMD) has launched new membership plans aimed at enhancing access to virtual primary care services. The innovative features in the proprietary mobile app now allow consumers to download it for free, gain access to a symptom checker, a discounted prescription card, and a live appointment queue for immediate virtual consultations. The company is introducing three membership tiers: FlexCare, which requires no membership fee; TotalCare, a quarterly plan that includes monthly visits; and ConciergeCare, which offers unlimited visits with a dedicated doctor. The expansion of these services is anticipated to support ongoing membership growth and positions LifeMD favorably in the evolving telehealth market, expected to see significant disruption by 2030 according to Bain and Co.
LifeMD, Inc. (NASDAQ: LFMD/LFMDP) announced a cash dividend of $0.5546875 per share on its 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP). The dividend will be paid on April 17, 2023, to shareholders on record as of April 7, 2023. This move reflects the company's commitment to providing returns to its preferred shareholders. LifeMD is a telehealth provider that offers a range of virtual healthcare services across the United States, leveraging a proprietary technology platform and nationwide pharmacy network to enhance healthcare accessibility.
LifeMD reported a significant milestone in Q4 2022, achieving consolidated Adjusted EBITDA profitability for the first time, totaling $631,000. Full Year 2022 consolidated revenue reached $119.0 million, a 28% increase year-over-year, despite a $2.9 million impact from deferred telehealth shipments in Q4. The company executed a $40 million debt financing agreement with Avenue Capital, bolstering its capital position for future growth. Guidance for 2023 indicates projected revenue of $140-$150 million and Adjusted EBITDA of $12-$18 million. Notably, active telehealth subscribers grew by 22% to approximately 169,000.
FAQ
What is the current stock price of Lifemd (LFMDP)?
